Timo Minssen



Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founder and Managing Director of UCPH's Center for Advanced Studies in Biomedical Innovation Law (CeBIL). His research concentrates on Intellectual Property-, Competition & Regulatory Law with a special focus on new technologies in the pharma, life science & biotech sectors. His studies comprise a phletora of legal issues emerging in the lifecycle of biotechnological and medical products and processes - from the regulation of research and incentives for innovation to technology transfer and commercialization. Timo is presenting frequently on a wide variety of pressing topics at international IP symposia, major law firms, the Universities of Oxford & Cambridge, Harvard Law School, MIT, and at the European Medicines Agency etc.. He has written 2 books and published 70+ articles and book chapters in leading international publications, such as Nature Biotech, PLoS-Computational Biology, Biotech. J., BLR, Person.Med., IIC, EIPR, ECLR, JIPLP, GRUR Int., Chi.-Kent J. Intell. Prop., IPQ, QMJIP, ERT, NIR & EUConst.LR. He is also a regular contributor on Harvard Law School's "Bill of Health" blog. Prior to founding CeBIL, Timo headed CIIR's Copenhagen Biotech & Pharma Forum (CBPF). Visit Timo Minssen's research homepage at: http://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631

Record last modified Nov 16, 2018 2:32:48 AM